IL21R and psoriasis: Moreover, neutralizing IL-21R with anti-mouse IL-21R antibody significantly reduces IMQ-mediated accumulation of MDSCs in skin lesions and splenic Th17 cells (Figure 5(c)), indicating targeting IL-21 is a therapeutic approach for psoriasis.